VolitionRX Ltd (VNRX) Scheduled to Post Earnings on Thursday
VolitionRX Ltd (NYSEMKT:VNRX) is scheduled to post its quarterly earnings results before the market opens on Thursday, August 10th. Analysts expect VolitionRX to post earnings of ($0.14) per share for the quarter.
VolitionRX (NYSEMKT:VNRX) last released its quarterly earnings results on Thursday, May 11th. The medical research company reported ($0.13) earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of ($0.14) by $0.01. On average, analysts expect VolitionRX to post $-0.56 EPS for the current fiscal year and $-0.57 EPS for the next fiscal year.
VolitionRX Ltd (NYSEMKT VNRX) opened at 3.05 on Tuesday. VolitionRX Ltd has a 12-month low of $2.92 and a 12-month high of $5.86. The firm’s market cap is $80.40 million. The stock has a 50 day moving average of $3.30 and a 200 day moving average of $3.84.
Separately, HC Wainwright reaffirmed a “buy” rating and set a $10.00 price objective on shares of VolitionRX in a research report on Friday, July 21st.
VolitionRX Company Profile
VolitionRx Limited is a clinical-stage life sciences company. The Company is focused on developing blood-based diagnostic tests for detecting and diagnosing cancer and other diseases. The Company has developed approximately 30 blood-based assays to detect specific biomarkers that can be used individually or in combination to generate a profile, which forms the basis of a test for a particular cancer or disease.
Receive News & Ratings for VolitionRX Ltd Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VolitionRX Ltd and related companies with MarketBeat.com's FREE daily email newsletter.